Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02538679Completed
Randomised, single-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Analgesic requirement in morphine equivalents at 24 hours. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02538679.